Literature DB >> 11123016

Pharmacologic therapy of osteoarthritis.

J P Pelletier1, D Choquette, B Haraoui, J P Raynauld, E Rich, J C Fernandes, J Martel-Pelletier.   

Abstract

This article presents a brief review of the most current therapies that are used for the relief of the symptoms related to osteoarthritis. The agents used either systematically or locally are described, providing the rationale for their usage in the treatment of osteoarthritis. Moreover, new therapies that have reached clinical evaluations and that can possibly reduce or stop the progression of the disease--namely the inhibitors of metalloproteases--are presented. Overall, it is obvious that significant progress has been made toward the development of new therapeutic agents to reduce the symptoms as well as the structural changes of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11123016     DOI: 10.1007/s11926-999-0026-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

1.  Nerve endings in human fasciae, tendons, ligaments, periosteum, and joint synovial membrane.

Authors:  H J RALSTON; M R MILLER; M KASAHARA
Journal:  Anat Rec       Date:  1960-02

Review 2.  An update on the epidemiology of knee and hip osteoarthritis with a view to prevention.

Authors:  D T Felson; Y Zhang
Journal:  Arthritis Rheum       Date:  1998-08

3.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

4.  Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.

Authors:  F Blotman; E Maheu; A Wulwik; H Caspard; A Lopez
Journal:  Rev Rhum Engl Ed       Date:  1997-12

5.  Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint.

Authors:  E J Valtonen
Journal:  Scand J Rheumatol Suppl       Date:  1981

6.  Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis.

Authors:  A C Jones; M Pattrick; S Doherty; M Doherty
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

7.  The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.

Authors:  M E Adams; M H Atkinson; A J Lussier; J I Schulz; K A Siminovitch; J P Wade; M Zummer
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

8.  Intra-articular steroids in osteoarthritis.

Authors:  P A Dieppe; B Sathapatayavongs; H E Jones; P A Bacon; E F Ring
Journal:  Rheumatol Rehabil       Date:  1980-11

9.  [Beneficial effects of treatment with diacerhein in guinea pigs with osteoarthritis].

Authors:  A M Bendele; R A Bendele; J F Hulman; B P Swann
Journal:  Rev Prat       Date:  1996-03-15

10.  Diacerhein in the treatment of osteoarthritis of the hip.

Authors:  M Nguyen; M Dougados; L Berdah; B Amor
Journal:  Arthritis Rheum       Date:  1994-04
View more
  3 in total

1.  Effectiveness of intra-articular injections of sodium bicarbonate and calcium gluconate in the treatment of osteoarthritis of the knee: a randomized double-blind clinical trial.

Authors:  Sandra García-Padilla; Miguel Angel Duarte-Vázquez; Karla Elena Gonzalez-Romero; María del Carmen Caamaño; Jorge L Rosado
Journal:  BMC Musculoskelet Disord       Date:  2015-05-13       Impact factor: 2.362

2.  A Double-Blind, Active-Controlled Clinical Trial of Sodium Bicarbonate and Calcium Gluconate in the Treatment of Bilateral Osteoarthritis of the Knee.

Authors:  María Del Carmen Caamaño; Sandra García-Padilla; Miguel Ángel Duarte-Vázquez; Karla Elena González-Romero; Jorge L Rosado
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-02-16

3.  MicroRNA-33 suppresses CCL2 expression in chondrocytes.

Authors:  Meng Wei; Qingyun Xie; Jun Zhu; Tao Wang; Fan Zhang; Yue Cheng; Dongyang Guo; Ying Wang; Liweng Mo; Shuai Wang
Journal:  Biosci Rep       Date:  2016-05-06       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.